Serum tumor markers, such as beta human chorionic gonadotropin (bHCG), alpha fetoprotein (AFP), and lactate dehydrogenase (LDH), hold acknowledged prognostic significance and are routinely and systematically incorporated into the conventional clinical protocols for the management of testicular cancer [5]. This evidence concerns the gene AFP and testicular cancer.